Economic evaluation of treatments for chronic hepatitis B.

Braz J Infect Dis · 2013 · PMC9428064 · PMID 23849851

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

might be significantno p-value reported

Moreover, there might be significant differences in the HBeAg seroconversion rate and viral resistant rate in the 1st and 2nd year of treatment.

also in 2,435 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.